Impact of the adjuvant management and risk factors on survival in FIGO stage 3 endometrial cancer patients

被引：0
|
作者：
Ko, J. J. [1 ]
Gelowitz, G. [1 ]
Tinker, A. V. [2 ]
Holloway, C. [3 ]
Kumar, A. [4 ]
机构：
[1] Abbotsford Reg Hosp & Canc Ctr, System Therapy, Abbotsford, BC, Canada
[2] BC Canc Agcy Vancouver, System Therapy, Vancouver, BC, Canada
[3] BC Canc Agcy Victoria, Radiat Oncol, Victoria, BC, Canada
[4] Fraser Valley Canc Ctr, Syst Therapy, Surrey, BC, Canada
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
976P
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Adjuvant chemotherapy and radiation for patients with high-risk stage I endometrial cancer treated with curative intent surgery: impact on recurrence and survival
    Findley, Rachelle
    Kooy, Joni
    Lester, Beverley
    Le, Nhu D.
    Bowering, Gale
    Rugayan, Christie
    Kumar, Aalok
    Glaze, Sarah
    Ko, Jenny
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 (04) : 508 - 516
  • [32] The Impact of Adjuvant Management on Survival Endpoints In Women With Stage I Type II Endometrial Carcinoma
    Hermann, Gregory M.
    Ibrahim, Ahmed M.
    Taylor, Andrew
    Tanbour, Hesham E.
    Elshaikh, Mohamed A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 98 (02): : E26 - E27
  • [33] ANALYSIS OF THE RISK FACTORS FOR THE OVERALL SURVIVAL IN PATIENTS WITH ENDOMETRIAL CANCER
    Molero Vilchez, J.
    Martinez Lamela, E.
    Sancho Garcia, S.
    Bancalari Rojnica, E.
    Fuentes Mateos, R.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1160 - 1160
  • [34] The efficacy of adjuvant chemotherapy on the survival of early stage endometrial cancer
    Yoneoka, Yutaka
    Amano, Tsukuru
    Tsuji, Shunichiro
    Uno, Masaya
    Ishikawa, Mitsuya
    Kato, Tomoyasu
    Murakami, Takashi
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2023, 287 : 155 - 160
  • [35] Adjuvant Therapy Use and Survival in Stage II Endometrial Cancer
    Lester-Coll, Nataniel H.
    Young, Melissa R.
    Park, Henry S.
    Ratner, Elena S.
    Litkouhi, Babak
    Damast, Shari
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 (09) : 1904 - 1911
  • [36] Chemotherapy as Adjuvant Treatment for Early Stage Endometrial Cancer With High Intermediate Risk Factors
    Gao, Min
    Zhang, Naiyi
    Song, Nan
    Zheng, Hong
    Yan, Xin
    Gao, Yunong
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 (07) : 1285 - 1289
  • [37] Role of adjuvant chemotherapy for patients with FIGO stage I high-intermediate risk endometrial carcinoma with lymphvascular invasion
    Nasioudis, Dimitrios
    McMinn, Erin
    Ko, Emily
    Haggerty, Ashley
    Cory, Lori
    Giuntoli, Robert
    Kim, Sarah
    Morgan, Mark
    Latif, Nawar
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S267 - S268
  • [38] Impact of adjuvant chemotherapy on survival for patients with Stage II colon cancer
    Stitzenberg, K. B.
    Stewart, A.
    Palis, B.
    Bilimoria, K.
    Minsky, B.
    Sigurdson, E.
    ANNALS OF SURGICAL ONCOLOGY, 2008, 15 : 89 - 89
  • [39] Analysis of Patients with 1988 FIGO Stage-II Endometrial Cancer
    Ureyen, Isin
    Turan, Taner
    Kimyon, Gunsu
    Karalok, Alper
    Tasci, Tolga
    Boran, Nurettin
    Tulunay, Gokhan
    Kose, M. Faruk
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2014, 24 (04): : 239 - 246
  • [40] Variation in modality of adjuvant therapy for advanced stage endometrial cancer and impact on associated survival outcomes
    Williams, K.
    Lin, L. L.
    Morgan, M. A.
    Kim, S. H.
    Latif, N. A.
    Haggerty, A. F.
    Giuntoli, R. L., II
    Ko, E. M.
    GYNECOLOGIC ONCOLOGY, 2018, 149 : 226 - 227
12345